Zydus Inspection 2025: VAI Revised

  Published 10 months ago

Inspection (June 9‑18, 2025) revised facility from OAI to VAI; Zydus Lifesciences develops global therapies.

  • The inspection period spanned ten days, assessing compliance, safety, and operational practices at the facility overall
  • 2024 classification indicated Official Action Required; 2025 revision downgraded to voluntary corrective measures for compliance
  • Zydus Lifesciences focuses on the discovery, development, manufacturing, and marketing of diverse healthcare therapies worldwide today

You might like these

R Systems Leads Everest 2025 Engineering

Welspun Q1 Revenue Jumps 24%

WestBridge Takes 15% Stake Edelweiss MF

Waaree-Kamath Deal Cancelled

Time Technoplast Sets Board Agenda

Exicom Announces Rights Issue & Debt-to-Equity Move

Asia's Gold Demand Slumps Amid High Prices and Rates

News that matters the most ⚡